Kevin King, CEO of Silicon Valley digital health company iRhythm, tells MassDevice about the promise of Big Data and how remote patient monitoring can reveal intricate details of the habits of the heart.
Westby G. Fisher, MD, FACC is a board certified internist, cardiologist, and cardiac electrophysiologist practicing at NorthShore University HealthSystem in Evanston, IL, USA and is a Clinical Associate Professor of Medicine at University of Chicago's Pritzker School of Medicine.
OCTANe and the Southern California Center of Technology & Innovation in Pediatrics join forces to spur innovation in pediatric medical devices and get more products to market.
MASSDEVICE ON CALL — Orange County, Calif., technology-backer OCTANe is teaming up with the Southern California Center of Technology & Innovation in Pediatrics (CTIP) to advance medical devices for chidren's health.
OCTANe plans to set up shop at the Children's Hospital of Las Angeles (CHLA), which operates the CTIP, to help commercialize new pediatric device with its "LaunchPad process of predictive analytics-based acceleration."
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
The IRS calculates that medtech companies paid the federal government $1.4 billion in medical device excise taxes in 2013, according to a response to a Freedom of Information Act request by MassDevice.com.
Medical device companies ponied up $1.4 billion in excise tax payments to the federal government in 2013 to pay for Obamacare, according to documents supplied to MassDevice.com by the Internal Revenue Service.
ResMed lands a permanent injunction barring rival Apex Medical from selling sleep-respiratory products that include headgear found to infringe on ResMed's patents.
Arch-rivals ResMed (NYSE:RMD) and Apex Medical each tallied wins this month in the long-running battle over sleep-base respiratory technologies, but ResMed took the lead with a German court decision to permanently bar certain Apex products.
Varian passes on an acquisition option as Augmenix closes a Series D funding round with $10.8 million raised in support of its Space OAR hydrogel for protecting the rectum during prostate radiation therapy.
Massachusetts-based Augmenix is hoping it can make it to the U.S. market with the $10.8 million funding round it just closed, the company said this month.
Here's a look at some of the top legal news stories for medical device companies this week: Judge nixes alleged settlement in Stryker, Biomet poaching spat; Boston Scientific loses bids to exclude testimony in pelvic mesh trials; Occlutech claims another win over St. Jude Medical; Align Tech declares a 'total win' as federal circuit reverses ITC ruling; Report: Medtronic shareholder sues to block Covidien merger